Literature DB >> 14699966

Neurotrophic factors in Huntington's disease.

Jordi Alberch1, Esther Pérez-Navarro, Josep M Canals.   

Abstract

Huntington's disease is a neurodegenerative disorder characterized by the selective loss of striatal neurons and, to a lesser extent, cortical neurons. The neurodegenerative process is caused by the mutation of huntingtin gene. Recent studies have established a link between mutant huntingtin, excitotoxicity and neurotrophic factors. Neurotrophic factors prevent cell death in degenerative processes but they can also enhance growth and function of neurons that are affected in Huntington's disease. The endogenous regulation of the expression of neurotrophic factors and their receptors in the striatum and its connections can be important to protect striatal cells and maintains basal ganglia connectivity. The administration of exogenous neurotrophic factors, in animal models of Huntington's disease, has been used to characterize the trophic requirements of striatal and cortical neurons. Neurotrophins, glial cell line-derived neurotrophic factor family members and ciliary neurotrophic factor have shown a potent neuroprotective effects on different neuronal populations of the striatum. Furthermore, they are also useful to maintain the integrity of the corticostriatal pathway. Thus, these neurotrophic factors may be suitable for the development of a neuroprotective therapy for neurodegenerative disorders of the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699966     DOI: 10.1016/s0079-6123(03)46014-7

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  27 in total

Review 1.  Experimental surgical therapies for Huntington's disease.

Authors:  Jelle Demeestere; Wim Vandenberghe
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 2.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

3.  FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.

Authors:  Kunlin Jin; Michelle LaFevre-Bernt; Yunjuan Sun; Sylvia Chen; Juliette Gafni; Danielle Crippen; Anna Logvinova; Christopher A Ross; David A Greenberg; Lisa M Ellerby
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

4.  Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor.

Authors:  Jordan M Fletcher; Craig J Morton; Richard A Zwar; Simon S Murray; Paul D O'Leary; Richard A Hughes
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

Review 5.  Brain-derived neurotrophic factor and the development of structural neuronal connectivity.

Authors:  Susana Cohen-Cory; Adhanet H Kidane; Nicole J Shirkey; Sonya Marshak
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

6.  Lasting changes induced by mild alcohol exposure during embryonic development in BDNF, NCAM and synaptophysin-positive neurons quantified in adult zebrafish.

Authors:  Samantha Mahabir; Dipashree Chatterjee; Keith Misquitta; Diptendu Chatterjee; Robert Gerlai
Journal:  Eur J Neurosci       Date:  2018-06-15       Impact factor: 3.386

7.  Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness.

Authors:  Jun Maruyama; Josef M Miller; Mats Ulfendahl
Journal:  Neurobiol Dis       Date:  2007-08-11       Impact factor: 5.996

8.  GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.

Authors:  Catarina A R V Gomes; Patrícia F Simões; Paula M Canas; César Quiroz; Ana M Sebastião; Sergi Ferré; Rodrigo A Cunha; Joaquim A Ribeiro
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

Review 9.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake.

Authors:  Corinne Beurrier; Mathilde Faideau; Khaled-Ezaheir Bennouar; Carole Escartin; Lydia Kerkerian-Le Goff; Gilles Bonvento; Paolo Gubellini
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.